ABVX – abivax sa - american depositary shares (US:NASDAQ)
Stock Stats
News
Abivax (NASDAQ:ABVX) had its price target raised by analysts at Morgan Stanley from $101.00 to $145.00. They now have an "overweight" rating on the stock.
Abivax (NASDAQ:ABVX) was given a new $131.00 price target on by analysts at Oppenheimer Holdings, Inc..
Abivax (NASDAQ:ABVX) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Abivax (NASDAQ:ABVX) had its "buy" rating reaffirmed by analysts at BTIG Research.
Abivax Provides 2026 Corporate Outlook
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.